CV Sciences (CVSI) Retained Earnings (2010 - 2026)
CV Sciences' (CVSI) quarterly Retained Earnings came in at -$88.6 million in Q1 2026, down 681500.0% year-on-year from N/an in Q1 2025, and down 0.73% quarter-over-quarter from -$87.9 million in Q4 2025.
CV Sciences (CVSI) Retained Earnings (2010 - 2026) Analysis & Trends
CV Sciences has disclosed Retained Earnings across 17 years of filings, most recently posting -$88.6 million for Q1 2026.
- Retained Earnings for Q1 2026 came in at -$88.6 million, down 681500.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$88.6 million (down 681500.0% YoY), and the FY2025 annual result was -$87.9 million, down 586160.0% from the prior year.
- Retained Earnings came in at -$88.6 million for Q1 2026 at CV Sciences, down from -$87.9 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $13000.0 in Q1 2025 to a low of -$88.6 million in Q1 2026.
- The 5-year median for Retained Earnings is -$83.7 million (2023), against an average of -$60.3 million.
- Peak annual rise in Retained Earnings reached 160.0% in 2025, while the deepest fall reached 4369900.0% in 2025.
- CV Sciences' Retained Earnings stood at -$87.7 million in 2022, then jumped by 100.01% to $10000.0 in 2023, then tumbled by 250.0% to -$15000.0 in 2024, then slumped by 586160.0% to -$87.9 million in 2025, then slipped by 0.73% to -$88.6 million in 2026.
- The last three Retained Earnings figures came in at -$88.6 million (Q1 2026), -$87.9 million (Q4 2025), and -$87.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn | -88.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -88.58 Mn |
| Dec 31, 2025 | -87.94 Mn |
| Sep 30, 2025 | -87.70 Mn |
| Jun 30, 2025 | -87.40 Mn |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | -15,000.00 |
| Sep 30, 2024 | -86.26 Mn |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 10,000.00 |
| Sep 30, 2023 | -83.72 Mn |
| Jun 30, 2023 | -83.30 Mn |
| Mar 31, 2023 | -82.00 Mn |
| Dec 31, 2022 | -87.69 Mn |
| Sep 30, 2022 | -85.38 Mn |
| Jun 30, 2022 | -84.30 Mn |
| Mar 31, 2022 | -81.70 Mn |
| Dec 31, 2021 | -79.48 Mn |
| Sep 30, 2021 | -70.62 Mn |
| Jun 30, 2021 | -70.58 Mn |